Related Experiment Video
Updated: Apr 15, 2026

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
Published on: November 28, 2025
Epidemiology and pathophysiology of Takotsubo syndrome
Yoshihiro J Akashi1, Holger M Nef2, Alexander R Lyon3
1Division of Cardiology, Department of Internal Medicine, St Marianna University School of Medicine, 2-16-1 Sugao Miyamae-ku, Kawasaki City, Kanagawa 216-8511, Japan.
Insights
Takotsubo syndrome, a heart condition, involves temporary left ventricular dysfunction. Its complex pathophysiology integrates neuroendocrine and sympathetic nervous system responses, with catecholamine cardiotoxicity playing a role.
Area of Science:
- Cardiology
- Neurocardiology
- Pathophysiology
Background:
- Takotsubo syndrome, first described in 1990, is an acute cardiac syndrome.
- Characterized by transient left ventricular dysfunction across multiple coronary artery territories.
- Potential for multiple, non-exclusive pathophysiological explanations.
Purpose of the Study:
- To explore the complex and multifactorial pathophysiology of Takotsubo syndrome.
- To integrate neuroendocrine, brain cognitive centers, and hypothalamic-pituitary-adrenal axis involvement.
- To understand the role of sympathetic activation and catecholamine cardiotoxicity.
Main Methods:
- Review of proposed pathophysiological explanations for Takotsubo syndrome.
- Integration of neuroendocrine and cardiovascular response mechanisms.
- Analysis of myocardial changes in relation to catecholamine exposure.
Main Results:
- Takotsubo syndrome pathophysiology is complex, involving neuroendocrine and sympathetic pathways.
- Catecholamine surge and cardiotoxicity correlate with observed myocardial changes.
- The syndrome's prognosis and recurrence rates are more severe than previously assumed.
Conclusions:
- Multiple pathophysiological phenomena likely contribute to Takotsubo syndrome.
- Understanding catecholamine cardiotoxicity is crucial for Takotsubo syndrome.
- Further research is needed to improve diagnosis and treatment of Takotsubo syndrome.
Abstract:
Takotsubo syndrome is an acute cardiac syndrome first described in 1990 and characterized by transient left ventricular dysfunction affecting more than one coronary artery territory, often in a circumferential apical, mid-ventricular, or basal distribution. Several pathophysiological explanations have been proposed for this syndrome and its intriguing appearance, and awareness is growing that these explanations might not be mutually exclusive. The reversible apical myocardial dysfunction observed might result from more than one pathophysiological phenomenon. The pathophysiology of Takotsubo syndrome is complex and integrates neuroendocrine physiology, potentially involving the cognitive centres of the brain, and including the hypothalamic-pituitary-adrenal axis. Cardiovascular responses are caused by the sudden sympathetic activation and surge in concentrations of circulating catecholamines. The multiple morphological changes seen in the myocardium match those seen after catecholamine-induced cardiotoxicity. The acute prognosis and recurrence rate are now known to be worse than initially thought, and much still needs to be learned about the epidemiology and the underlying pathophysiology of this fascinating condition in order to improve diagnostic and treatment pathways.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Heart Failure II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Myocarditis I: Introduction
